Key result
Salvianolic acid B improves preclinical myocardial ischemia by regulating autophagy to inhibit apoptosis and promote angiogenesis.
Why the study?
Angiogenesis promotes tissue repair and reduces cell damage in myocardial ischemia, prompting investigation into whether Salvianolic acid B provides protection through autophagy regulation.
Does Salvianolic acid B reduce cardiomyocyte apoptosis and promote angiogenesis in myocardial ischemia models?
Does Salvianolic acid B reduce cardiomyocyte apoptosis and promote angiogenesis in myocardial ischemia models?
Salvianolic acid B protects against myocardial ischemia by inhibiting cardiomyocyte apoptosis and promoting angiogenesis through the regulation of autophagy.
Salvianolic acid B merits further preclinical testing in myocardial ischemia; leaves open any role in human therapy.
BACKGROUND: Myocardial ischemia (MI) can cause angina, myocardial infarction, and even death. Angiogenesis is beneficial for ensuring oxygen and blood supply to ischemic tissue, promoting tissue repair, and reducing cell damage. In this study, we evaluated the effects of Salvianolic acid B (Sal B) against myocardial ischemia and explored its underlying mechanism on autophagy. METHODS: The anti-apoptosis effect of Sal B was conducted by staining Annexin V-FITC/PI and Hoechst as well as evaluating apoptosis bio-markers at protein level in H9c2 cells at glucose deprivation condition. HUVECs were co-cultured with H9c2, and the tube formation assay was used to monitor Sal B's impact on angiogenesis. The MI model of mice was induced by intraperitoneal injection of isoproterenol (ISO). The effect of Sal B on MI mice was evaluated by HE, Masson, immunohistochemistry, WB and kits. In addition, Atg5 siRNA was applied to verify whether the protective effect of Sal B was regulated to autophagy. RESULTS: In H9c2, Sal B reduced the levels of lactate dehydrogenase (LDH), malondialdehyde (MDA) and reactive oxygen species (ROS), improved the levels of superoxide dismutase (SOD) and mitochondrial membrane potential, downregulated the expressions of Bax and cleaved-Caspase3, upregulated the expression of Bcl-2. Therefore, Sal B could significantly inhibit the damage of H9c2 caused by glucose deprivation. In the co-culture system of H9c2 and HUVECs, vascular endothelial growth factor (VEGF) level in the supernatant was dramatically raised by Sal B. Sal B upregulated the expressions of VEGF, platelet derived growth factor (PDGF) and endothelial marker CD31. It implied that Sal B exerted a significant pro-angiogenic effect. Moreover, Sal B increased the expression of LC3, Atg5, and Beclin1, while reducing the level of P62. When the expression of Atg5 was inhibited, the protective effects of Sal B on apoptosis and angiogenesis was reversed. CONCLUSIONS: Sal B inhibited cardiomyocyte apoptosis and promoted angiogenesis by regulating autophagy, thereby improving MI.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied Myocardial ischemia (n=20). Salvianolic acid B vs. Isoproterenol (ISO) alone or with Atg5 siRNA was evaluated. Salvianolic acid B inhibited cardiomyocyte apoptosis and promoted angiogenesis by regulating autophagy, thereby improving myocardial ischemia in preclinical models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: